Skip to main content
. 2013 Mar 26;8(3):e58217. doi: 10.1371/journal.pone.0058217

Table 3. Clinical factors for candida esophagitis on uni- and multivariable analysis (n = 733).

Clinical factors CE (+) (n = 62) CE (−) (n = 671) Odds ratio (95% CI) P
Univariate analysis
Age (years)
<40 21 236 1 (referent)
≥40 41 435 1.06 (0.60–1.93) 0.84
Sex
Female 7 46 1 (referent)
Male 55 625 0.58 (0.24–1.59) 0.19
Sexual behavior
Heterosexual 23 249 1 (referent)
MSM 39 422 1.00 (0.57–1.80) 1.00
CD4+ cell count (cells/μL)
>200 19 388 1 (referent)
100-199 4 134 0.61 (0.20–1.82)
<100 39 149 5.35 (2.99–9.55) <0.01
HIV-RNA VL (copies/mL)
≤40 (normal range) 10 376 1 (referent)
40<VL≤10,000 13 123 3.97 (1.70–9.29)
10,000<VL≤100,000 15 84 6.71 (2.91–15.5)
100,000< VL 24 88 10.3 (4.73–22.2) <0.01
History of HAART
Without 30 158 1 (referent)
With 32 513 0.33 (0.19–0.58) <0.01
GI symptoms
Without 35 435 1 (referent)
With 27 236 1.42 (0.81–2.48) 0.18
Multivariate analysis
CD4+ cell count (cells/μL)
>200 19 388 1 (referent)
100-199 4 134 0.43 (0.14–1.30)
<100 39 149 2.82 (1.46–5.46) <0.01
HIV-RNA VL (copies/mL)
≤40 (normal range) 10 376 1 (referent)
40<VL≤10,000 13 123 3.67 (1.54–8.74)
10,000<VL≤100,000 15 84 5.34 (2.24–12.7)
100,000< VL 24 88 5.67 (2.39–13.4) <0.01

Abbreviations: CE, Candida esophagitis; MSM, men who have sex with men; VL: viral load; HAART, highly active antiretroviral therapy.